₹ 32.75
NAV (Jul 28)
View Less
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
Expense Ratio | 1.22 % |
Launched 6Y ago | 2019-02-28 |
AUM in Crores | 87.7 |
ISIN | INF397L01LK4 |
Lock-in (days) | No Lock-in |
Benchmark | BSE Healthcare Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation | 16 |
Beta | 0.9 |
Sharpe Ratio | 0.6 |
Sun Pharmaceutical Industries Ltd.
11.53%Artemis Medicare Services Ltd.
7.01%Piramal Pharma Ltd.
6.47%Glenmark Pharmaceuticals Ltd.
6.32%JB Chemicals & Pharmaceuticals Ltd.
5.86%Healthcare
91.24%Chemicals
6.39%Fund Name | Fund Size | |
---|---|---|
₹ 110,392 cr | ||
₹ 72,336 cr | ||
₹ 79,584 cr | ||
₹ 30,616 cr | ||
₹ 17,427 cr |